🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Kazia Therapeutics Limited

KZIA Healthcare
$13.52 +$0.31 (2.35%)
Market Cap: $154.49 M
Gurus Holding
2
Popularity Rank
#3691
% of Shares Held
2.19%
Net Activity (Q2 2026)
+$707,451.16

Guru Ownership Trend

Guru Analysis for Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics Limited (KZIA), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.38 M.

Top institutional holders include Steven Cohen and Leon Cooperman.

Institutional sentiment is currently Bullish. This is evidenced by a $707,451.16 net inflow during the quarter.

Recent activity highlights Leon Cooperman who opened a new position.

Key Holders

Top 5 by Value

$2.3 M
$704,000

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$707,451.16
Total Buy Value
New Buys 1
Additions 1
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
0
Net Buyers
2

FAQs for Kazia Therapeutics Limited (KZIA)

Major holders include Steven Cohen ($2.3 M), Leon Cooperman ($704,000). According to the latest reported data, 2 tracked investment managers collectively hold approximately 250,300 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $707,451.16, with 2 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in KZIA during the most recent reporting period.

Yes, 1 managers opened new positions in KZIA, and 1 increased their existing holdings. The total reported buy value was $707,451.16.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 0.2% 200,300 $2.3 M Q2 2026
0.02% New Buy 50,000 $704,000 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form